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Objective and Aim. An imbalance of the sympathetic system may explain many of the clinical manifestations of the migraine. We
aimed to evaluate P-waves as a reveal of sympathetic system function in migraine patients and healthy controls. Materials and
Methods. Thirty-ﬁve episodic type of migraine patients (complained of migraine during 5 years or more, BMI < 30kg/m2)a n d3 0
controls were included in our study. We measured P-wave durations (minimum, maximum, and dispersion) from 12-lead ECG
recording during pain-free periods. ECGs were transferred to a personal computer via a scanner and then used for magniﬁcation
of x400 by Adobe Photoshop software. Results. P-wave durations were found to be similar between migraine patients and controls.
Although P WD (P-wave dispersion) was similar, the mean value was higher in migraine subjects. P WD was positively correlated
with P max (P<0.01). Attacks number per month and male gender were the factors related to the P WD (P<0.01). Conclusions.
Many previous studies suggested that increased sympathetic activity may cause an increase in P WD. We found that P WD of
migraine patients was higher than controls, and P WD was related to attacks number per month and male gender. Further studies
are needed to explain the chronic eﬀects of migraine.
1.Introduction
It is widely accepted that symptoms of migraine are related
to the involvement of the autonomic nervous system, and
dysfunction may aﬀect atrial and ventricular repolarization.
The sympathetic nervous system is known to play an
important role in the genesis of ventricular arrhythmias [1].
QT interval changes and P-wave changes may be predictors
of atrial and ventricular arrhythmias. The most signiﬁcant
one is prolonged QT interval, which is a predictor of
ventricular arrhythmias [2]. In addition, P-wave dispersion
which is a predictor of atrial ﬁbrillation (AF) is deﬁned
as the diﬀerence between maximum and minimum P-wave
duration and has been associated with inhomogeneous and
discontinuous propagation of sinus impulses [3, 4]. It has
been shown that increased sympathetic activity caused a
signiﬁcant elevation in P-wave dispersion [5]. It has also
been reported that there was an association between the
autonomic nervous system and atrial ﬁbrillation [6, 7].
Although the previous reports reﬂected atrial and ven-
tricular repolarization abnormalities that were aﬀected by
disturbed ANS (sympathetic and/or parasympathetic ner-
vous system dysfunction) during migraine attacks, the asso-
ciation between atrial ﬁbrillation and migraine is limited to
case reports only [8–12]. Duru et al. reported that maximum
P-wave duration (P max) and P-wave disperson (P WD)
werefoundhigherduringmigraineattacksthanduringpain-
free periods [13]. However, P WD was not reported during
pain-free period which might be a shower of damage related
toattacksuntilnowincomparisontohealthycontrols.Inthis
study, we tried to ﬁnd whether the patients with migraine
may go under the risk of atrial and ventricular arrhythmias
or not. For this reason, we undertook evaluation of P-wave
dispersion as a sign of autonomic dysfunction in patients2 The Scientiﬁc World Journal
Table 1: Sociodemographical and clinical variables and P-wave durations in comparison.
Variable Migraine group (n = 35) Controls (n = 30) P value
Age (year) 34.60 ±7.54 35.87 ±6.97 0.48
Gender 0.25
Male 6 9
Female 29 21
Number of the patients
with aura 14
without aura 21
Duration of migraine (hour) 22.43 ±22.85 (range: 3.0–72.0)
Attack number per month 3.37 ±1.63 (range: 2.0–8.0)
VAS score 7.63 ±2.11 (range: 4.0–10.0)
P min value (ms) 41.81 ±8.02 42.36 ±8.07 0.78
P max value (ms) 95.97 ±12.89 91.21 ±10.05 0.11
P WD value (ms) 54.55 ±13.44 50.40 ±11.63 0.19
with well-deﬁned migraine during headache-free period and
compared to normal healthy controls.
2. Methods
Thirty-ﬁveepisodictypeofmigrainepatients(complainedof
migraine during 5 years or more, BMI < 30kg/m2), and age
and sex-matched 30 healthy controls were included in our
study.
The diagnosis of migraine was made using criteria of
the International Headache Society [14]. Thirty-ﬁve subjects
with migraine were evaluated during the pain-free period;
14 with migraine with aura (MWA) and 21 with migraine
without aura (MWOA). We conﬁned the study to women
aged 20 to 45 years who had suﬀered from migraine for more
than 1 year and had at least one migraine attack per month.
Thepresenceofotherpainsyndromes(e.g.,chroniclowback
pain or chronic tension-type headache), systemic disease
(e.g., diabetes mellitus), and disorders that could aﬀect the
autonomic nervous system were exclusionary. Except for
mild analgesics, all drugs were withdrawn 5 days before the
testing, and no drug, including caﬀeine, or cigarettes, was
allowed on the day of testing. The control group (n = l6)
consisted of age and sex-matched persons who were free of
migraine, other chronic pain syndromes, systemic diseases,
or disorders that could aﬀect the autonomic nervous system.
These subjects were not on any medication. The study
protocol was approved by the Institutional Review Board.
Autonomic tests were performed in the headache-free
period. None of the subjects reported headache for at
least 72h before and after testing. Subjects were instructed
to abstain from caﬀeine-containing beverages and, in the
adolescents,fromnicotine andalcoholforatleast24hbefore
the test. The examinations took place between 14.00h and
17.00h to avoid diurnal variation and were performed in
aw a r mr o o m( 2 4 ◦C). The subjects were asked to lie down
and not to move during recording. The ECG recording
was performed. Heart rate, P max and minimum P-wave
duration (P min), and P WDwere measured from 12-lead
ECG recording during pain-free periods. The diﬀerence
between the maximum and minimum P-wave duration was
deﬁned as P WD. ECGs were transferred to a personal
computer via a scanner and then used for magniﬁcation of
x400 by Adobe Photoshop software.
Intra- and interobserver coeﬃcients of variation (stan-
dard deviation [SD] of diﬀerences between 2 observations
divided by the mean value and expressed in percent) were
found as 3.7% and 3.8% for P-wave dispersion. Intra and
interobserver coeﬃcients of variation were found to be
less than 5%. All data were presented as mean value ±
SD. Comparison of clinical variables between 2 groups was
performed with paired Student t-test for numeric variables
and chi-square test for categorical data. A P value < 0.05 was
considered to be statistically signiﬁcant. The SPSS version
11.0 package was used in statistical analysis.
3. Results
Sociodemographical and clinical ﬁndings and P-wave values
were summarized in Table 1. Ten patients were using Trip-
tans, 10 patients were using anti-inﬂammatory or analgesic
agents, and 15 patients were using combinations. P min was
found to be similar between migraine patients and controls.
Although P WD and P max values of migraine patients were
similar in migraine patients and healthy controls, the mean
values were higher in migraine subjects as seen in Table 1. P
WDwaspositivelycorrelatedwithP max(P<0.001).Onthe
other hand, attacks number per month (P<0.001) and male
gender (P = 0.03) were the factors related to the P WD. In
addition,P maxwaspositivelycorrelatedwithage(P<0.05).
VAS score was higher in females (P = 0.02). The presence of
aura did not aﬀect P value.
4. Discussion
Aura symptoms, gastrointestinal symptoms, and photosen-
sitivity or phonosensitivity may be an imbalance of the
sympathovagal imbalance in migraine patients [9, 15, 16].The Scientiﬁc World Journal 3
Inaddition,supportingsympatheticdysfunction,thesystolic
blood pressure overshoot during the Valsalva maneuver
was found to be decreased in migraineurs with aura [15].
Dysfunction of the ANS may aﬀect atrial and ventricular
repolarization. For example, increased sympathetic activity
causes increased heart rate. Therefore, disrupted autonomic
innervation of the heart and coronary arteries in patients
with migraine may result in possible electrocardiographic
(ECG) abnormalities during headache. Some case-control
studiesofcardiovascularfunctionreportedbothsympathetic
hyperfunction [16–18] and sympathetic hypofunction [19]
even using single-lead ECG monitoring during migraine
compared with a pain-free period.
Reduced parasympathetic and increased sympathetic
nervous system (SNS) activity can lower the threshold for
atrial ﬁbrillation. Some previous studies have reported the
association between the ANS and atrial ﬁbrillation [20, 21].
But we have limited information on the association between
atrial ﬁbrillation and migraine. Duru et al. have shown that
the migraine attacks were associated with increased QTc
and P-wave dispersion compared with pain-free periods in
a recent paper. Then, they concluded that patients with
migraine during attacks were associated with increased QTc
and P-wave dispersion because of a disrupted autonomic
nervous system in migraine patients [13]. However, P-wave
dispersion was not reported during pain-free period which
might be a shower of damage related to attacks until now.
In this study, we tried to ﬁnd whether the patients with
migraine may be under the risk of atrial and ventricular
arrhythmiasornot.Forthisreason,weundertookevaluation
of P-wave dispersion as a sign of autonomic dysfunction
in patients with well-deﬁned migraine during headache-
free period and compared to normal healthy controls. In
our study, we found that P max and P min were similar
between migraine patients and controls. Similarly, Aygun
et al. reported that ECG abnormalities particularly PR and
corrected QT (QTc) interval lengthening often were present
during a migraine attack, and these abnormalities would
be absent or less prominent during pain-free intervals [22].
Duru et al. also found that ECG abnormalities including
P-wave dispersion were more prominent during migraine
attack[13].Inadditiontothispreviousknowledgeswefound
thatthemeanvalueofP WDwashigherinmigrainesubjects,
and P WD was positively correlated with P max.
In conclusion, we believe that increased sympathetic
activity may cause signiﬁcant increase in P WD of migraine
patients.Theattacksnumberpermonthandmalegenderare
the factors aﬀecting the P WD, so the patients with higher
numbers of attack may go under the risk of autonomic-
dysfunction-related problems in the future.
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